Market Overview:
The market growth can be attributed to the increasing prevalence of MPS diseases, rising awareness about MPS treatments, and technological advancements in the field of stem cell therapies and enzyme replacement therapies. However, high costs associated with MPS treatments may restrain the growth of this market in some regions. On the basis of application, this market can be segmented into hospitals, clinics, and homecare. Geographically, this market can be segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . North America is expected to dominate this market during the forecast period owing to factors such as increasing prevalence of MPS diseases in this region and availability of advanced technologies for treating these diseases.
Product Definition:
MPS Treatment can help improve the quality of life for those who are affected by this condition.
Stem Cell Therapies:
Stem cell therapies are the new kid on the block in MPS treatment market. The concept of stem cells has been around for quite some time, but only recently have they gained significant attention in terms of their therapeutic potential. Stem cells can be defined as those cells that possess the ability to differentiate into different types of tissues and organs; these include embryonic, adult or induced (i.e., from cord blood), and umbilical cord stem cells (UCS).
Enzyme Replacement Therapies:
The enzyme replacement therapy includes use of man-made substrate or genetically engineered enzymes for replacing the deficient enzyme activity. This therapy is used as a treatment or as a prophylactic measure for MPS diseases, which are caused by an inability of human enzymes to properly digest glycosaminoglycans (GAGs).
Application Insights:
The global market is segmented by application into hospitals, clinics and other healthcare facilities, and homecare settings. Hospitals held the largest share in 2017 owing to availability of advanced treatment facilities for MPS patients. Moreover, hospitals are considered as the most prominent centers for diagnosis due to highly skilled medical staff available in these institutions.
Clinics and other healthcare facilities are projected to witness lucrative growth over the forecast period due to increasing awareness about MPS among individuals suffering from this disorder. Furthermore, rising demand for minimally invasive surgeries is anticipated to boost product demand from 2018 to 2030 during this period. Minimally invasive surgeries involve use of small incisions rather than large ones which help reduce pain & recovery time as well as allow easy access inside organs & tissues thus contributing towards lucrative growth of clinics over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of patients suffering from MPS, increased healthcare expenditure, and availability of reimbursement coverage for stem cell therapies and enzyme replacement therapy in U.S. Moreover, high prevalence of MPSDs among newborns in U.S.
Growth Factors:
- Increasing prevalence of MPS disorders
- Growing awareness about MPS treatment options
- Rising number of clinical trials for MPS treatments
- increasing investment in R&D for novel MPS therapies
- Technological advancements in the field of gene therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Mucopolysaccharidosis (MPS) Treatment Market Research Report
By Type
Stem Cell Therapies, Enzyme Replacement Therapies
By Application
Hospitals, Clinics, Homecare
By Companies
Sanofi, Shire (Takeda), BioMarin Pharmaceutical, Esteve, REGENXBIO Inc, Sangamo Therapeutics, Ultragenyx Pharmaceutical, Abeona Therapeutics, ArmaGen, Eloxx Pharmaceuticals, Inventiva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Mucopolysaccharidosis (MPS) Treatment Market Report Segments:
The global Mucopolysaccharidosis (MPS) Treatment market is segmented on the basis of:
Types
Stem Cell Therapies, Enzyme Replacement Therapies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Shire (Takeda)
- BioMarin Pharmaceutical
- Esteve
- REGENXBIO Inc
- Sangamo Therapeutics
- Ultragenyx Pharmaceutical
- Abeona Therapeutics
- ArmaGen
- Eloxx Pharmaceuticals
- Inventiva
Highlights of The Mucopolysaccharidosis (MPS) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stem Cell Therapies
- Enzyme Replacement Therapies
- By Application:
- Hospitals
- Clinics
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mucopolysaccharidosis (MPS) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no cure for MPS, but there are treatments that can help improve the symptoms. Treatment options may include enzyme replacement therapy, a feeding tube, and physical therapy.
Some of the key players operating in the mucopolysaccharidosis (mps) treatment market are Sanofi, Shire (Takeda), BioMarin Pharmaceutical, Esteve, REGENXBIO Inc, Sangamo Therapeutics, Ultragenyx Pharmaceutical, Abeona Therapeutics, ArmaGen, Eloxx Pharmaceuticals, Inventiva.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mucopolysaccharidosis (MPS) Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Mucopolysaccharidosis (MPS) Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Mucopolysaccharidosis (MPS) Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Mucopolysaccharidosis (MPS) Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Mucopolysaccharidosis (MPS) Treatment Market Size & Forecast, 2018-2028 4.5.1 Mucopolysaccharidosis (MPS) Treatment Market Size and Y-o-Y Growth 4.5.2 Mucopolysaccharidosis (MPS) Treatment Market Absolute $ Opportunity
Chapter 5 Global Mucopolysaccharidosis (MPS) Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type
5.2.1 Stem Cell Therapies
5.2.2 Enzyme Replacement Therapies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mucopolysaccharidosis (MPS) Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Homecare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mucopolysaccharidosis (MPS) Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mucopolysaccharidosis (MPS) Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type
9.6.1 Stem Cell Therapies
9.6.2 Enzyme Replacement Therapies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Homecare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mucopolysaccharidosis (MPS) Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type
10.6.1 Stem Cell Therapies
10.6.2 Enzyme Replacement Therapies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Homecare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mucopolysaccharidosis (MPS) Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type
11.6.1 Stem Cell Therapies
11.6.2 Enzyme Replacement Therapies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Homecare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mucopolysaccharidosis (MPS) Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type
12.6.1 Stem Cell Therapies
12.6.2 Enzyme Replacement Therapies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Homecare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mucopolysaccharidosis (MPS) Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type
13.6.1 Stem Cell Therapies
13.6.2 Enzyme Replacement Therapies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Homecare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mucopolysaccharidosis (MPS) Treatment Market: Competitive Dashboard
14.2 Global Mucopolysaccharidosis (MPS) Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Shire (Takeda)
14.3.3 BioMarin Pharmaceutical
14.3.4 Esteve
14.3.5 REGENXBIO Inc
14.3.6 Sangamo Therapeutics
14.3.7 Ultragenyx Pharmaceutical
14.3.8 Abeona Therapeutics
14.3.9 ArmaGen
14.3.10 Eloxx Pharmaceuticals
14.3.11 Inventiva